TL;DR: Nabla Bio is a Y Combinator Summer 2020 startup We use AI to design antibodies for intractable diseases, currently active with a team of 8.
We use AI to design antibodies for intractable diseases
Last verified:
Our mission is to enable pharmaceutical and biotech companies to bring more antibody therapies to patients. Using AI and massively parallel experimentation, we design antibodies that precisely bind the disease target at the right location, while minimizing manufacturability and toxicity risks. We are a well-funded, revenue-generating, bilingual company of wet- and dry-lab scientists, and are founded by AI and protein design experts from Harvard University.
Built by LemStudio
Yes. Nabla Bio was funded by Y Combinator in the Summer 2020 batch. We use AI to design antibodies for intractable diseases
Our mission is to enable pharmaceutical and biotech companies to bring more antibody therapies to patients. Using AI and massively parallel experimentation, we design antibodies that precisely bind the disease target at the right location, while minimizing manufacturability and toxicity risks. We are a well-funded, re…
Nabla Bio was part of Y Combinator's Summer 2020 batch.
Nabla Bio has a team of 8 people according to Y Combinator's directory.
Nabla Bio is currently listed as Active with a team of 8 in Y Combinator's directory.
Loading interactive view…